These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 26387028)

  • 41. Cardioprotective Effects of Nicorandil on Coronary Heart Disease Patients Undergoing Elective Percutaneous Coronary Intervention.
    Pang Z; Zhao W; Yao Z
    Med Sci Monit; 2017 Jun; 23():2924-2930. PubMed ID: 28617765
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of upstream tirofiban versus downstream tirofiban on myocardial damage and 180-day clinical outcomes in high-risk acute coronary syndromes patients undergoing percutaneous coronary interventions.
    Liu T; Xie Y; Zhou YJ; Li YP; Ma HY; Guo YH; Liu YY; Zhao YX; Shi DM
    Chin Med J (Engl); 2009 Aug; 122(15):1732-7. PubMed ID: 19781316
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Significant association between admission serum monocyte chemoattractant protein-1 and early changes in myocardial function in patients with first ST-segment elevation myocardial infarction after primary percutaneous coronary intervention.
    Zhu Y; Hu C; Du Y; Zhang J; Liu J; Han H; Zhao Y
    BMC Cardiovasc Disord; 2019 May; 19(1):107. PubMed ID: 31077149
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of a 180 mg ticagrelor loading dose on myocardial necrosis in patients undergoing elective percutaneous coronary intervention: A preliminary study.
    Xu Q; Sun Y; Zhang Y; Liu B; Fang L; Shen C; Li Y; Meng S
    Cardiol J; 2017; 24(1):15-24. PubMed ID: 28070882
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Association between high sensitivity C-reactive protein and contrast induced acute kidney injury in patients with acute coronary syndrome undergoing percutaneous coronary intervention: impact of atorvastatin].
    Su JZ; Xue Y; Cai WQ; Huang QY; Chai DJ; Chen GL; Wang FB; Chen XP; Zhang DS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Sep; 39(9):807-11. PubMed ID: 22321227
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Non-ST-elevation acute coronary syndrome. Comparison of effects of atorvastatin and rosuvastatin on blood levels of lipids and markers of inflammation].
    Kuznetsova MA; Vaulin NA; Masenko VP; Gratsianskiĭ NA
    Kardiologiia; 2010; 50(2):21-5. PubMed ID: 20146674
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic impact of intensive statin therapy on N-terminal pro-BNP level in non-ST-segment elevation acute myocardial infarction patients.
    Shehata M; Samir A; Dardiri M
    J Interv Cardiol; 2017 Dec; 30(6):514-521. PubMed ID: 28812321
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dose-dependent INhibitory effect of rosuVastatin In Japanese patienTs with Acute myocardial infarcTION on serum concentration of matrix metalloproteinases - INVITATION trial.
    Fujisue K; Shirakawa T; Nakamura S; Yamamoto N; Oshima S; Matsumura T; Tsunoda R; Hirai N; Tayama S; Nakamura N; Hirose T; Maruyama H; Fujimoto K; Kajiwara I; Sakamoto T; Nakao K; Sakaino N; Hokimoto S; Nagayoshi Y; Hokamaki J; Shimomura H; Sakamoto K; Yamamoto E; Izumiya Y; Kaikita K; Ogawa H; Tsujita K;
    J Cardiol; 2018 Oct; 72(4):350-355. PubMed ID: 29735336
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of Loading Dose of Atorvastatin Prior to Planned Percutaneous Coronary Intervention on Major Adverse Cardiovascular Events in Acute Coronary Syndrome: The SECURE-PCI Randomized Clinical Trial.
    Berwanger O; Santucci EV; de Barros E Silva PGM; Jesuíno IA; Damiani LP; Barbosa LM; Santos RHN; Laranjeira LN; Egydio FM; Borges de Oliveira JA; Dall Orto FTC; Beraldo de Andrade P; Bienert IRC; Bosso CE; Mangione JA; Polanczyk CA; Sousa AGMR; Kalil RAK; Santos LM; Sposito AC; Rech RL; Sousa ACS; Baldissera F; Nascimento BR; Giraldez RRCV; Cavalcanti AB; Pereira SB; Mattos LA; Armaganijan LV; Guimarães HP; Sousa JEMR; Alexander JH; Granger CB; Lopes RD;
    JAMA; 2018 Apr; 319(13):1331-1340. PubMed ID: 29525821
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Prevention of periprocedural kidney ingury by loading doses of statins in elective percutaneous сoronary interventions].
    Vershinina EO; Repin AN; Timofeev MS; Udut VV
    Kardiologiia; 2018 SMay; (S5):20-29. PubMed ID: 29894673
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Improved Cardiac Function and Attenuated Inflammatory Response by Additional Administration of Tirofiban during PCI for ST-Segment Elevation Myocardial Infarction Patients.
    Zhang J; Ding G
    Evid Based Complement Alternat Med; 2021; 2021():8371996. PubMed ID: 34221091
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intensive statin therapy stabilizes C-reactive protein, but not chemokine in stable coronary artery disease treated with an everolimus-eluting stent.
    Sukegawa H; Maekawa Y; Yuasa S; Anzai A; Kodaira M; Takei M; Sano F; Ueda I; Kawakami T; Hayashida K; Kohno T; Kohsaka S; Abe T; Fukuda K
    Coron Artery Dis; 2016 Aug; 27(5):405-11. PubMed ID: 27105046
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Platelet reactivity in patients receiving a maintenance dose of P2Y12-ADP receptor antagonists undergoing elective percutaneous coronary intervention.
    Bonello L; Laine M; Thuny F; Paganelli F; Lemesle G; Roch A; Kerbaul F; Dignat-George F; Berbis J; Frere C
    Int J Cardiol; 2016 Aug; 216():190-3. PubMed ID: 27179310
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of statin therapy on coronary intervention for non-ST elevation acute coronary syndrome with decreased low-density lipoprotein cholesterol.
    Hara H; Nakamura M; Yokouchi I; Kimura K; Nemoto N; Ito S; Ono T; Shiba M; Wada M; Tsuji T; Komatsu H; Iijima R; Nakajima R; Yamamoto M; Yamamoto M; Yoshitama T; Takagi T; Hara H; Sugi K
    J Cardiol; 2007 Mar; 49(3):115-23. PubMed ID: 17444137
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of rosuvastatin therapy on troponin I release following percutaneous coronary intervention in nonemergency patients (from the TIP 3 study).
    Veselka J; Hájek P; Tomašov P; Tesař D; Brůhová H; Matějovič M; Branny M; Studenčan M; Zemánek D
    Am J Cardiol; 2014 Feb; 113(3):446-51. PubMed ID: 24304551
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy of early intensive rosuvastatin therapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (ROSEMARY Study).
    Ko YG; Won H; Shin DH; Kim JS; Kim BK; Choi D; Hong MK; Bae JH; Lee S; Lim DS; Jang Y
    Am J Cardiol; 2014 Jul; 114(1):29-35. PubMed ID: 24831577
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High sensitive C-reactive protein and the risk of acute kidney injury among ST elevation myocardial infarction patients undergoing primary percutaneous intervention.
    Shacham Y; Leshem-Rubinow E; Steinvil A; Keren G; Roth A; Arbel Y
    Clin Exp Nephrol; 2015 Oct; 19(5):838-43. PubMed ID: 25492251
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Timing of Loading Dose of Atorvastatin in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndromes: Insights From the SECURE-PCI Randomized Clinical Trial.
    Lopes RD; de Barros E Silva PGM; de Andrade Jesuíno I; Santucci EV; Barbosa LM; Damiani LP; Nakagawa Santos RH; Laranjeira LN; Dall Orto FTC; Beraldo de Andrade P; de Castro Bienert IR; Alexander JH; Granger CB; Berwanger O
    JAMA Cardiol; 2018 Nov; 3(11):1113-1118. PubMed ID: 30264159
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of Vitamin D in the Prevention of Myocardial Injury Following Elective Percutaneous Coronary Intervention: A Pilot Randomized Clinical Trial.
    Aslanabadi N; Jafaripor I; Sadeghi S; Hamishehkar H; Ghaffari S; Toluey M; Azizi H; Entezari-Maleki T
    J Clin Pharmacol; 2018 Feb; 58(2):144-151. PubMed ID: 28841229
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy of high-dose clopidogrel treatment (600 mg) less than two hours before percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes.
    Feldman DN; Fakorede F; Minutello RM; Bergman G; Moussa I; Wong SC
    Am J Cardiol; 2010 Feb; 105(3):323-32. PubMed ID: 20102943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.